Biotechnology Stocks I Performance Guide: Apogee Therapeutics, Inc. (APGE)
APGE has no dividends.
Table and Chart of APGE Performance
See what a $1,000 investment in APGE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| APGE Returns | |
|---|---|
| Start Date | Aug-31-2023 |
| Start Price | $22.94 |
| End Date | May-08-2024 |
| End Price | $51.26 |
| # Prices | 10 |
| Min Date | Oct-31-2023 |
| Min Price | $17.18 |
| Max Date | Mar-28-2024 |
| Max Price | $66.45 |
| Total Return | 123.45% |
| Annualized Return | 162.44% |
| Current Value of $1,000 Purchase | $2,235 |
| Number Returns | 45 |
| Average Return | 78.06% |
| Number Profitable Returns | 38 |
| Percent Profitable Returns | 84.44% |
| Number Unprofitable Returns | 7 |
| Percent Unprofitable Returns | 15.56% |
| Profitable to Unprofitable Returns Ratio | 5.43 |
| APGE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,995,942,000 |
| Beta | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $72.29 |
| 52 Week Low | $14.19 |
| Analyst Target Price | $85.8 |
| 50-Day Moving Average | $56.2 |
| 200-Day Moving Average | $32.22 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -32.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
APGE Compare Returns with S&P 500
APGE Trendline Chart
APGE Moving Average Chart
APGE Stock Return Map - See Patterns of Gains and Losses
APGE Stock Returns/Purchase Dates